In the future, we intend to try several therapies to block the induction of the UV-induced B cell lymphomas in p53+/- mice including PAF receptor antagonist PCA-4248 treatment [55] or anti-IL-10 antibody therapy [56]. The gene discussed is IL10; the disease is B-cell non-Hodgkin lymphoma.